Cancer and neoplasms
Main inclusion criteria
All types of neoplasms, including benign, potentially malignant, malignant (cancer) and canerous growths. This includes leukaemia and mesothelioma.
Advice on health categories
Do not code to the site of the cancer. However if the research involves studying a condition that predisposes to cancer then it may be appropriate to code for this condition as well.
e.g. The role of Barrett’s oesophagus in cancer would be 50% Oral and Gastrointestinal and 50% Cancer.
Similarly research on pathogens associated with the development of cancer should be coded as 50% Cancer and 50% Infection.
Studies of the normal role of oncogenes, tumour suppressor genes, and cell cycle checkpoints in a non diseased cell should be coded as 50% Generic Health Relevance and 50% Cancer.
Excludes general studies of angiogenesis which should be coded as Cardiovascular. However the development of anti-angiogenic drugs to inhibit tumour growth would be coded as Cancer.
Excludes normal studies of cell cycle and DNA replication and repair which should be coded as Generic.
Official terminology
|
Full name of category |
Short name | Unique ID |
| Cancer | Cancer |
HRCS_HC_02CAN |
Related external links
International Classification of Diseases (ICD 10 v2016) – Chapter II: Neoplasms (C00-D48)